Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Findings from the Budget Calculator guide you in prioritizing goals and shaping a realistic plan. Use them to steer your financial journey.
20,466 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A mid-2026 move by a hedge fund to exit EPAM Systems sparked questions about portfolio risk and disclosure. This guid...
As Baozun charts its path in 2026, investors want clarity on revenue growth, margins, and strategic bets. This articl...
Investors are weighing Micron's AI-driven demand against a volatile memory market. This guide breaks down whether you...
Chipmakers led U.S. equities higher, helping the S&P 500 reach a new close. This piece breaks down what moved markets...
Alphabet and Meta are steering through a redefining ad market shaped by AI investment. This piece compares valuation,...
After Friday’s tech retreat, a leading wall street strategist argues that cybersecurity presents the larger, longer-t...
Jeff Bezos reveals a bold new venture positioned to accelerate invention cycles and expand global prosperity, challen...
In a live AMA, Charles Hoskinson addresses a disputed stash of 1,096 BTC from Cardano’s early fundraiser, explaining ...
SpaceX is not publicly traded, but exposure can hide in retirement funds. Analysts say large mutual funds and 401(k) ...
A new bipartisan housing bill aims to curb investor hoarding and expand aid for first-time buyers. The measure would ...
Investors poured into bitcoin ETFs this week, reversing prior outflows as appetite for regulated crypto exposure retu...